Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)

202411 citationsJournal Articlegold Open Access

Authors

ANRS Emerging infectious diseases (ANRS MIE); Vaccine Research Institute (VRI).

Good health and well-being

Published in: EClinicalMedicine

Volume 77, pp. 102845-102845

Field-Weighted Citation Impact: 2.65